BACE1 and Dravet syndrome: Recently, it was reported that lowering the expression of APP or beta-site APP-cleaving enzyme 1 (BACE-1), reversed endocytic abnormalities in fibroblasts derived from people with DS, and the over-expression of APP alone resulted in early endosome enlargements[100].